Pseudobulbar Affect (PBA)

DBCOND0038672Mental DisordersNervous System Diseases

Pseudobulbar Affect (PBA) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Pseudobulbar affect
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM000769014ICD-10F48.2SNOMED CT432776007MedDRA10023532UMLSC0233472

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Pseudobulbar Affect (PBA) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In